Scroll to top
© 2020, Startuprecipe theme by Rssow

Report Generator empowers organizations to track and target critical IT sustainability issues

2024/03/21

Report Generator empowers organizations to track and target critical IT sustainability issues

Using TCO Certified just became more valuable. The new Report Generator allows organizations to create customized sustainability reports on their IT product portfolios – based on independently verified data and claims covered by the stringent social and environmental criteria of...

2024/03/21

FDA Grants Orphan Drug Designation to Cevidoplenib for ITP

PANGYO, South Korea, March 21, 2024 /PRNewswire/ — Oscotec Inc. has secured orphan drug designation (ODD) from the U.S. Food and Drug Administration (FDA) for its SYK inhibitor, Cevidoplenib, to treat immune thrombocytopenia (ITP). Oscotec has successfully completed phase 2...

2024/03/21

HanAll Biopharma Reports Full-Year 2023 Financial Results and Provides Business Update

Full-year 2023 net revenue reaches 135 billion KRW, driven by strong sales growth. R&D momentum persisted with promising developments in anti-FcRn antibodies HL161ANS and batoclimab, positioning them as potentially best-in-class treatments for lgG-mediated autoimmune diseases. Anticipates the initiation of tanfanercept Phase 3...

2024/03/21

iQIYI's 'Action Master' Season Unveils Diverse Charm of Martial Arts Films

Innovative Multi-line Distribution Model Optimizes Audience Targeting BEIJING, March 21, 2024 /PRNewswire/ — iQIYI, an innovative market-leading online entertainment service in China, has recently concluded the first season of ‘Action Master,’ showcasing the multifaceted allure of action movies. Throughout the...

2024/03/21

ATFX Welcomes Graham Morris as the New Head of Compliance for Australia

SYDNEY, March 21, 2024 /PRNewswire/ — ATFX recently announced that Graham Morris has been appointed as Head of Compliance for ATFX’s operations in Australia. Graham is set to bring a vast reservoir of compliance expertise and industry knowledge to the...

2024/03/21

Four Rising Stars at 30th GILF showcasing industrial innovation, originality, and momentum

ZHONGSHAN, China, March 21, 2024 /PRNewswire/ — The 30th China (Guzhen) International Lighting Fair (hereinafter referred to as GILF) opened grandly on March 18th at the Guzhen Convention and Exhibition Center in Zhongshan City, Guangdong Province, China. At this main venue,...

2024/03/21

NEC opens new Operations Center to expand its presence to Johor.

JOHOR BAHRU, Malaysia, March 21, 2024 /PRNewswire/ — NEC Corporation of Malaysia (NEC Malaysia), a leading digital transformation technology provider, today launched its Intelligent Center Operations of NEC (ICON) as part of its plans to expand its presence in Johor....

2024/03/21

Agoda, GSTC, and USAID Partner to Champion Sustainability Education for Hotels in Asia

SINGAPORE, March 21, 2024 /PRNewswire/ — Digital travel platform Agoda, the Global Sustainable Tourism Council (GSTC), and the United States Agency for International Development (USAID) have partnered  to provide sustainability trainings for hoteliers across Asia, which will strengthen the sustainability transformation...

2024/03/21

Cognizant and Google Cloud Expand AI Partnership to Drive Software Development Productivity

Cognizant will adopt Gemini for Google Cloud to accelerate velocity for its software developers and enable more than 70,000 associates on Google Cloud’s latest AI technologies TEANECK, N.J. and SUNNYVALE, Calif., March 21, 2024 /PRNewswire/ — Cognizant (NASDAQ: CTSH) and Google...

2024/03/21

Together with Industry Giants, TVU Networks Redefines Broadcasting at NAB 2024

Discover pioneering solutions developed in collaboration with the world’s leading media companies. CUPERTINO, Calif., March 21, 2024 /PRNewswire/ — TVU Networks, a global pioneer in cloud and IP-based live video technologies, announced their full cloud ecosystem will be on display...

2024/03/21

Aggreko Powers KPMG Australia Sail Grand Prix in Sydney with HVO

MELBOURNE, Australia, March 21, 2024 /PRNewswire/ — Energy solutions company Aggreko, world leader in the supply of modular power, proudly announces its groundbreaking partnership with KPMG Australia Sail Grand Prix in Sydney, powering the event with an environmentally friendly approach...

2024/03/21

The 2024 Smart City Summit & Expo - Ministry of Transportation and Communications Begets the " Smart Transportation Vision Pavilion"

Smart technology enables real-time aggregation and application of comprehensive transportation data from the central to local levels across land, sea, and air domains  A Holistic View Taken to Achieve Urban-Rural Collaboration TAIPEI, March 21, 2024 /PRNewswire/ — The Ministry of Transportation...

2024/03/21

Enabot Unveils ROLA PetPal and ROLA PetTracker, Forging Unbreakable Bonds Between Pets and Owners

ORLANDO, Fla., March 21, 2024 /PRNewswire/ — Enabot is thrilled to announce the official launch of their latest innovations in pet tech: the ROLA PetPal and ROLA PetTracker. Over six years, Enabot has emerged as a leader in family robotics with...

2024/03/21

AI Gaming Takes the Lead! GIGABYTE G6X AI Gaming Laptop is Now Available

TAIPEI, March 21, 2024 /PRNewswire/ — GIGABYTE, the world’s leading computer brand, announces the highly anticipated GIGABYTE G6X, a cutting-edge 16-inch AI gaming laptop unveiled at CES 2024 is now available for purchase. Equipped with the Intel® Core™ 13th gen...

2024/03/20

Antengene Initiates Phase II Dose Expansion Study of Claudin 18.2 ADC ATG-022 in China and Australia

SHANGHAI and HONG KONG, March 20, 2024 /PRNewswire/ — Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hematology and oncology, today announced that it has initiated...

2024/03/20

Antennova Completes First Dosing Cohort for Anti-CD24 mAb, ATN-031, in the Phase I PERFORM Study

ATN-031 (also known as ATG-031), is the first anti-CD24 antibody to advance to the clinic in oncology in the United States The Phase I PERFORM trial, ongoing at four major U.S. cancer centers, is evaluating the safety and preliminary efficacy...

Access to the latest Korean startup news and startup database for free

sign up for Startup Recipe newsletter